Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0009 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |